Device will not carry concentric collapse contraindication or warning language ...

Hypoglossal nerve stimulation therapy approved in the U.S. without complete concentric collapse contraindication or warning language. The next-generation, MRI-compatible device is expected to launch ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. AD109 is taken orally and once daily before bedtime.

Credit: Nyxoah. Genio is a bilateral hypoglossal nerve stimulation system that consists of an implantable stimulator and a sleep wearable. The Genio system is now available in the US for OSA patients ...

A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...

Researchers conduct the first meta-analysis comparing hypnotics in OSA patients, finding most are safe but flagging temazepam for oxygen risks.

Obstructive sleep apnea (OSA) is typically measured on a scale called the apnea-hypopnea index (AHI), which determines how many times you stop breathing (apnea) and how often your breathing is ...

Please provide your email address to receive an email when new articles are posted on . IHL-42X is a combination pharmacotherapy for OSA. IHL-42X groups had greater decreases in disease severity vs.

Symptom severity of obstructive sleep apnea (OSA) worsens significantly on the weekends and is likely associated with increased alcohol use and smoking, irregular sleep schedules, and lack of OSA ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea (OSA) reduced the number of nightly breath-stopping events by 46.8%, smashing the ...